Saturday 17 October 2026
Export EVH’s income statement to Excel — free account
Evolent Health, Inc
EVH Healthcare Health Information Services
Evolent Health, Inc’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 26.6% from fiscal 2024. In the quarter to June 2026, revenue grew 46.9%, EPS grew 43.2%, free cash flow grew 58.7% and total debt rose 49.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.57
0.30
−6.16%
Follow EVH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 4 | 3 |
+8 more TTM periods Free account |
| (79.90%) | (80.15%) | (81.81%) | (19.23%) | ||
| (23.05%) | (23.55%) | (26.08%) | (7.30%) | ||
ROIC |
(22.06%) | (21.76%) | (21.22%) | (0.73%) | |
Return on Tangible Assets |
(256.04%) | (264.31%) | (286.98%) | (82.13%) | |
Average Days of Receivables |
78.17 | 60.71 | 60.28 | 68.69 | |
Free Cash Flow per Share |
0.22 | 0.01 | 0.04 | (0.60) | |
Free Cash Flow |
24.34 | 1.40 | 4.76 | (68.67) | |
Capital Expenditures |
(29.98) | (31.90) | (34.09) | (32.48) | |
| Other line items | |||||
Cash ROIC |
1.64% | 0.09% | 0.30% | (3.37%) | |
Accounts Receivable Turnover |
5.19 | 5.07 | 5.18 | 5.17 | |
Accounts Payable Turnover |
32.05 | 24.96 | 18.95 | 27.41 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.17 | 15.25 | 14.78 | 15.72 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.92% | 15.79% | 16.20% | 13.58% | |
Share Based Compensation of Revenue |
2.05% | 2.08% | 2.12% | 1.52% | |
Interest Coverage |
(6.18) | (6.55) | (7.14) | (0.45) | |
Operating CF/Net income |
(0.11) | (0.06) | (0.07) | 0.20 | |
Depreciation/Fixed assets |
6.44 | 6.50 | 6.54 | 1.41 | |
Capex/Depreciation |
(0.06) | (0.06) | (0.06) | (0.29) | |
Revenue per Share |
18.63 | 16.88 | 16.43 | 18.01 | |
Operating CF per Share |
0.48 | 0.30 | 0.34 | (0.32) | |
Capex per Share |
(0.27) | (0.29) | (0.30) | (0.28) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates